Epigenetic mechanisms in breast cancer therapy and resistance
Liliana Garcia-Martinez1,2, Yusheng Zhang1,2, Yuichiro Nakata1,2
1Sylvester Comprehensive Cancer Center, Miami, FL, USA.
Abstract:
The majority of breast cancers express the estrogen receptor (ERα) and agents targeting this pathway represent the main treatment modality. Endocrine therapy has proven successful in the treatment of hormone-responsive breast cancer since its early adoption in the 1940s as an ablative therapy. Unfortunately, therapeutic resistance arises, leading to disease recurrence and relapse. Recent studies increased our understanding in how changes to the chromatin landscape and deregulation of epigenetic factors orchestrate the resistant phenotype. Here, we will discuss how the epigenome is an integral determinant in hormone therapy response and why epigenetic factors are promising targets for overcoming clinical resistance.
Related Concept Videos
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...


